How to explain the conflicting reports on all-cause mortality in the comparison of MASLD-only group with no-SLD group?
Authors:
Open Access
- 1 March 2025
- journal article
- letter
- Published by Springer Nature in Hepatology International
- Vol. 19 (3) , 694
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Is MetALD an independent risk factor of all-cause mortality? A meta-analysis of 164,694 individuals from the real worldJournal of Hepatology, 2024
- Is MASLD a real culprit for all-cause mortality? A meta-analysis and preliminary pathophysiology exploration in the real worldJournal of Hepatology, 2024
- Clinical features and mortality outcomes of patients with MASLD only compared to those with MAFLD and MASLDHepatology International, 2024
- Progress is impossible without change: understanding the evolving nomenclature of steatotic liver disease and its effect on hepatology practiceThe Lancet Gastroenterology & Hepatology, 2024
- Reply: A multi-society Delphi consensus statement on new fatty liver disease nomenclatureHepatology, 2023
- A multisociety Delphi consensus statement on new fatty liver disease nomenclatureAnnals of Hepatology, 2023